| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 5Y869C2THE |
| InChI Key | NXMZBNYLCVTRGB-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H19N3O3S |
| Molecular Weight | 393.47 |
| AlogP | 3.87 |
| Hydrogen Bond Acceptor | 6.0 |
| Hydrogen Bond Donor | 0.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 73.56 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 28.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Cyclooxygenase-2 inhibitor | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | 3-3 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Arthritis, Rheumatoid | 3 | D001172 | ClinicalTrials |
| Osteoarthritis, Knee | 3 | D020370 | ClinicalTrials |
| Toothache | 3 | D014098 | ClinicalTrials |
| Pain | 1 | D010146 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL364804 |
| DrugBank | DB12009 |
| EPA CompTox | DTXSID60202043 |
| FDA SRS | 5Y869C2THE |
| Guide to Pharmacology | 9850 |
| PubChem | 9832687 |
| SureChEMBL | SCHEMBL309320 |
| ZINC | ZINC000000583671 |